P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG

K. Paris; I. Hussain; A. Darter; L. Kobrynski; T. Berner; B. McCoy; C. Rabbat; L. Yel

首页> 外文期刊>Annals of allergy, asthma, and immunology >P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG

【24h】

P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG

机译：PIDD患者IG20GLY的P281不良事件和输注参数，其预研究治疗是IVIG

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology 》 |2017年第5期| 共2页
作者
K. Paris; I. Hussain; A. Darter; L. Kobrynski; T. Berner; B. McCoy; C. Rabbat; L. Yel;
展开▼
作者单位

New Orleans LA;

Tulsa OK;

Oklahoma City OK;

Atlanta GA;

Chicago IL;

Cambridge MA;

Chicago IL;

Cambridge MA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学 ;
关键词

相似文献

外文文献
中文文献
专利

1. P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG [J] . K. Paris, I. Hussain, A. Darter, Annals of allergy, asthma, and immunology . 2017 ,第5期

机译：PIDD患者IG20GLY的P281不良事件和输注参数，其预研究治疗是IVIG
2. ADVERSE EVENTS AND INFUSION PARAMETERS OF IG20GLY IN PIDD PATIENTS WHOSE PRE-STUDY TREATMENT WAS IVIG [J] . Paris K., Hussain I., Darter A., Annals of allergy, asthma, and immunology . 2017 ,第5Suppla1期

机译：PIDD患者IG20GLY的不良事件和输注参数，其预研究治疗是IVIG
3. ADVERSE EVENTS AND INFUSION PARAMETERS OF IG20GLY IN PIDD PATIENTS WHOSE PRE-STUDY TREATMENT WAS IVIG [J] . Paris K., Hussain I., Darter A., Annals of allergy, asthma, and immunology . 2017 ,第5Suppla1期

机译：PIDD患者IG20GLY的不良事件和输注参数，其预研究治疗是IVIG
4. Characterization of Nervous System Adverse Events in Patients taking Ziconotide Intrathecal Infusion for Severe Chronic Pain [C] . L. Gee, T. Marmon, A. Narayana, International Neuromodulation Society., Meeting . 2005

机译：患有ZicoNotide鞘内输注对严重慢性疼痛的患者神经系统不良事件的特征
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison [O] . TAKASHI TSUDA, CHISATO KYOMORI, TAKURO MIZUKAMI, -1

机译：接受高度催吐化学疗法联合阿瑞吡坦和福沙泼坦预防性止吐的乳腺癌患者的输注部位不良事件：回顾性比较
7. PCV83 - KEY MODEL PARAMETERS AND METHODOLOGIES USED IN COST-EFFECTIVENESS ANALYSIS EVALUATING TREATMENTS FOR SECONDARY PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS WITH A PRIOR MYOCARDIAL INFARCTION (MI) OR ACUTE CORONARY SYNDROME (ACS) [O] . R. Jindal, G. Partha, S. Cholasamudram, 2018

机译：PCV83 - 成本效益分析的关键模型参数和方法，用于评估患有先前心肌梗死（MI）或急性冠状动脉综合征（ACS）的主要不良心血管事件（MACE）的重大不良心血管事件（MACE）的次要预防治疗

P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG

著录项

相似文献

相关主题

期刊订阅